Does Dr. RIAZ AHMED have financial conflicts of interest?

Dr. RIAZ AHMED (M.D.) has received a total of $2,582 in pharmaceutical and medical device industry funding between 2021 and 2024. This includes $2,582 in personal promotional payouts (consulting, meals, travel) and $0 in clinical research grants. Financial ties do not automatically imply conflict of interest, but are disclosed under the Sunshine Act.

Which pharmaceutical companies pay Dr. RIAZ AHMED?

According to CMS Open Payments data, Dr. RIAZ AHMED received funding from NOVARTIS PHARMACEUTICALS CORPORATION ($319), JANSSEN PHARMACEUTICALS ($285), and E.R. SQUIBB & SONS, L.L.C ($255).

Does Dr. RIAZ AHMED receive research grants or speaking fees?

Dr. RIAZ AHMED has received $2,582 in general promotional payments (such as consulting honoraria, meals, and speaking fees) and $0 in clinical research grants.

DR. RIAZ AHMED

M.D.Real-Time Hydrated

Specialty: Internal Medicine, Cardiovascular Disease

Practice Location: ENCINITAS, CA 92024

NPI Number: 1376593871

LIFETIME INDUSTRY VALUE

$2,582

2021 – 2024 Cumulative

Conflict of Interest Analysis

Dr. AHMED is a verified Internal Medicine, Cardiovascular Disease practitioner based in ENCINITAS, CA.

Between 2021 and 2024, Dr. AHMED had an overall industry promotional and research financial footprint of $2,582 as recorded in the federal CMS Open Payments database.

$2,582 was received in general payments, which include consultation fees, travel expenses, honoraria, and sponsored meals.
$0 was allocated to sponsored clinical trials and medical research activities.

Dr. AHMED's primary funding source is NOVARTIS PHARMACEUTICALS CORPORATION, which accounts for $319 (representing 12.3% of overall industry footprint).

Data coverage: 2021 – 2024 · Source: CMS Open Payments · CMS publishes each year's data around June 30 of the following year.

Payout Trend Over Time

General Payments

Research Funding

Top Funding Entities

Pharmaceutical & Device Manufacturers making direct payments

NOVARTIS PHARMACEUTICALS CORPORATION

Rank 1

$319

12.3%

JANSSEN PHARMACEUTICALS

Rank 2

$285

11%

E.R. SQUIBB & SONS, L.L.C

Rank 3

$255

9.9%

Itemized Transaction Archives

Direct live query to Socrata CMS Open Payments API (Bypasses local DB)

Year:

2024

Filter < $250

Click "Load Live Logs" to query the federal Open Payments registry directly.

Frequently Asked Questions

Answers compiled using federal transparency disclosure records under the Sunshine Act.